Boasting reduced hospitalizations, Merck Covid pill awaits approval
Merck, the science and tech company, has urged regulatory agencies in the United States to grant authorization for use of its pill to treat Covid-19
Stay updated with breaking news from Fda Clearance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Merck, the science and tech company, has urged regulatory agencies in the United States to grant authorization for use of its pill to treat Covid-19
Merck, the science and tech company, has urged regulatory agencies in the United States to grant authorization for use of its pill to treat Covid-19
Merck, the science and tech company, has urged regulatory agencies in the United States to grant authorization for use of its pill to treat Covid-19
Merck, the science and tech company, has urged regulatory agencies in the United States to grant authorization for use of its pill to treat Covid-19
Merck, the science and tech company, has urged regulatory agencies in the United States to grant authorization for use of its pill to treat Covid-19